Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-03-05 @ 8:50 AM
Study NCT ID:
NCT00087568
Status:
COMPLETED
Last Update Posted:
2016-06-08
First Post:
2004-07-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-12
First Submit QC Date:
None
Study First Post Date:
2004-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-03
Results First Submit QC Date:
None
Results First Post Date:
2016-06-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-02
Last Update Post Date:
2016-06-08
Last Update Post Date Type:
ESTIMATED